Biodesix, Inc. (BDSX)
Largest Insider Buys in Sector
BDSX Stock Price History Chart
BDSX Stock Performance
About Biodesix, Inc.
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer …
Insider Activity of Biodesix, Inc.
Over the last 12 months, insiders at Biodesix, Inc. have bought $821,546 and sold $220,281 worth of Biodesix, Inc. stock.
On average, over the past 5 years, insiders at Biodesix, Inc. have bought $28.65M and sold $198,219 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SCHULER JACK W () — $2.96M. Strobeck Matthew (director) — $223,664. PATIENCE JOHN (Chairman) — $207,420.
The last purchase of 100,000 shares for transaction amount of $122,840 was made by SCHULER JACK W () on 2024‑11‑21.
List of Insider Buy and Sell Transactions, Biodesix, Inc.
| 2024-11-21 | 100,000 0.0687% | $1.23 | $122,840 | +12.92% | ||||
| 2024-11-21 | 35,000 0.0227% | $1.16 | $40,562 | +12.92% | ||||
| 2024-11-20 | 200,000 0.1375% | $1.17 | $234,000 | +13.45% | ||||
| 2024-11-12 | Sale | President & CEO | 1,813 0.0013% | $1.40 | $2,540 | -3.57% | ||
| 2024-11-12 | Sale | CFO, Sec'y & Treasurer | 471 0.0003% | $1.40 | $660 | -3.57% | ||
| 2024-11-12 | Sale | Chief Development Officer | 207 0.0001% | $1.40 | $290 | -3.57% | ||
| 2024-11-12 | Sale | Chief Commercial Officer | 224 0.0002% | $1.40 | $314 | -3.57% | ||
| 2024-11-12 | Sale | Chief Accounting Officer | 98 <0.0001% | $1.40 | $137 | -3.57% | ||
| 2024-11-11 | Sale | President & CEO | 1,927 0.0013% | $1.39 | $2,680 | -4.26% | ||
| 2024-11-11 | Sale | CFO, Sec'y & Treasurer | 500 0.0003% | $1.39 | $695 | -4.26% | ||
| 2024-11-11 | Sale | Chief Development Officer | 220 0.0001% | $1.39 | $306 | -4.26% | ||
| 2024-11-11 | Sale | Chief Commercial Officer | 238 0.0002% | $1.39 | $331 | -4.26% | ||
| 2024-11-11 | Sale | Chief Accounting Officer | 105 <0.0001% | $1.39 | $146 | -4.26% | ||
| 2024-11-06 | 20,000 0.0139% | $1.36 | $27,180 | +1.88% | ||||
| 2024-11-05 | 100,253 0.0679% | $1.36 | $136,585 | -0.91% | ||||
| 2024-11-05 | 51,200 0.0348% | $1.36 | $69,888 | -1.10% | ||||
| 2024-11-05 | director | 40,000 0.0278% | $1.40 | $55,916 | -3.43% | |||
| 2024-11-05 | Chairman | 75,000 0.0516% | $1.38 | $103,710 | -2.37% | |||
| 2024-11-05 | director | 22,500 0.0154% | $1.37 | $30,866 | -1.59% | |||
| 2024-08-12 | Sale | President & CEO | 963 0.0007% | $1.57 | $1,514 | +2.48% |
Insider Historical Profitability
| SCHULER JACK W | 31194935 21.4447% | $1.57 | 31 | 0 | <0.0001% | |
| Kennedy Lawrence T. Jr | 10411024 7.157% | $1.57 | 5 | 0 | +22.69% | |
| Strobeck Matthew | director | 2606879 1.7921% | $1.57 | 6 | 0 | +0.18% |
| PATIENCE JOHN | Chairman | 2153298 1.4803% | $1.57 | 10 | 0 | <0.0001% |
| Hutton Scott | President & CEO | 532979 0.3664% | $1.57 | 2 | 20 | <0.0001% |
Institutional Investor Ownership
| Birchview Capital Lp | $7.42M | 4.53 | 5.19M | 0% | +$0 | 0.41 | |
| Aigh Capital Management Llc | $4.75M | 2.9 | 3.32M | -28.72% | -$1.91M | 2.72 | |
| Telemark Asset Management LLC | $1.9M | 1.16 | 1.33M | +1,644.74% | +$1.79M | 0.21 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1.32M | 0.81 | 925,614 | +1.39% | +$18,116.67 | 0.27 | |
| Wells Fargo | $1.28M | 0.78 | 893,203 | +1.08% | +$13,656.51 | <0.0001 |